| Name | Support | Language | Availability | Edition date | Price | ||
|---|---|---|---|---|---|---|---|
|
PDF |
English |
Active |
11/1/2010 |
€193.00 |
|
||
Details
Approved Guideline--Second Edition recognizes the increased use of quantitative molecular methods for determining the
concentration of microorganisms in patients. CLSI document MM06 provides guidance for the development and use of
quantitative molecular methods, such as nucleic acid probes and nucleic acid amplification techniques of the target sequences
specific to particular microorganisms, and presents recommendations for quality assurance, proficiency testing, and interpretation
of results.
Issues specific to the quantification of nucleic acid in diagnostic testing and monitoring, particularly in viral diseases, include an
update on technologies used in molecular quantification, specimen handling and preparation, standards, calibrators, and reference
materials, analytical and clinical verification/validation, reporting and interpreting results, clinical utility, and recommendations
for manufacturers and clinical laboratories.
Additional Info
| Author | Clinical and Laboratory Standards Institute (CLSI) |
|---|---|
| Published by | CLSI |
| Document type | Standard |
| Theme | /subgroups/17908 |
| Confirmation date | 2018-01-01 |
| EAN ISBN | 1562387367 |
| Number of pages | 80 |
| Replace | CLSI MM06A |
| Keyword | CLSI MM06-A2 (R2018) |
